KTTA · Pasithea Therapeutics Corp.
$0.57
+0.01 (+1.79%)
At close · Aug 26
Market Cap
$19.01M
Shares
33.41M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
20,819,956 shares
as of 2023-09-30
· not restated in filings since 2023-11-13
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-11-26 | 2025-06-20 | $4,227,000 | — | — | 10-K , filed 2026-03-30 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2023-12-31 | $3,726,416 | 10-K, filed 2025-03-24 |
Key facts
CIK
1841330
CUSIP
70261F202
13F (30d)
32 filings
31 filers
Visit website
Investor relations